Hepalink

About Hepalink

Hepalink Group, dual-listed in Hong Kong and mainland China, is emerging as a global leader in the heparin industry, backed by nearly 30 years of expertise and driven by mature industrial and commercial platforms. Hepalink is the No. 1 global manufacturer & distributor of biosimilar enoxaparin injections. Its API production facility has passed zero 483 inspections 7 times. Hepalink has sales in over 50 countries and regions and operates 8 manufacturing sites around the world.